Navigation Links
Arthrosurface Launches World's First Talus Resurfacing Implant for the Ankle
Date:10/24/2011

FRANKLIN, Mass., Oct. 24, 2011 /PRNewswire/ -- Arthrosurface, Inc. (www.arthrosurface.com), the developer of less-invasive joint resurfacing systems, announced that it has launched its HemiCAP® Talus Resurfacing System for damage to the ankle in Europe and other international markets.  Prior to commercialization, the HemiCAP® Talus System was tested by well known Foot and Ankle surgeons throughout Europe in a four year clinical evaluation. The company reports that results from over 100 implantations indicated a very high level of patient satisfaction.

Prof. Dr. C. Niek van Dijk, Department of Orthopaedic Surgery, Academic Medical Center, University of Amsterdam, said "Metallic implantation with the HemiCAP® system offers a promising new solution for those patients who have failed their primary treatment. For these young and active patients it is important to restore the damaged area in order to protect the underlying bone and prevent further cyst formation.  I am very encouraged by our clinical results over the last four years."

Focal defects of the talar dome are often caused by trauma and result in deep, cup-shaped lesions. This incongruity of the joint surface and resulting cartilage damage often alters contact stresses in the ankle joint and can likely lead to development of painful cysts deep within the bone.  As pain sensing nerves exist in the bone, it is these cysts and fluid pressure on areas of exposed bone that can cause significant pain and debilitation.

Dr. Ned Amendola, Professor of Orthopaedics and Director of Sports Medicine at the University of Iowa, said "The HemiCAP® Talus Resurfacing System allows surgeons to restore the damaged surface of the talar dome by reproducing three surfaces with one implant, namely the dome, ridge and medial wall. In our study we showed that the HemiCAP® Talus System re-approximates the native geometry of the talar dome providing a load sharing surface to help protect the remaining rim of good cartilage."

The company reports that previous alternatives available to patients after failing primary treatment were to opt for total ankle replacements or ankle fusions.  Each of these options are associated with compromises for the patient as an ankle replacement removes a significant amount of bone and has a higher risk of failure than other joint replacements and fusion permanently eliminates the movement of the ankle joint. The company boasts that the HemiCAP® Talus implant now gives patients another option that is significantly less invasive, preserves the joint and allows for normal activity.

The Arthrosurface HemiCAP® Talus System is part of its Focal to Total Joint Platform Technology that offers over 150 different sizes and shapes to effectively cover the damaged area and precisely match the contours of the patients' joint surface as measured at the time of surgery.


'/>"/>
SOURCE Arthrosurface, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Arthrosurface Continues to Expand into Fast Growing Shoulder Market
2. Arthrosurface® Hits the 20,000 Implant Milestone
3. DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing
4. Prometheus Launches Next Generation IBD Diagnostic Test
5. Market Education Tactics and Strategies to Support Successful Oncology Product Launches
6. IRIDEX Launches New MicroPulse™ Module Targeting the Broad Ophthalmology Laser Photocoagulation Market
7. TRACE Launches Leading Edge Anti-Bribery Compliance Software
8. Boston Scientific Launches Promus Element™ Stent System In China
9. Archimedes Pharma Launches Lazanda® - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S.
10. Masimo Launches the 2011 Radical-7 with rainbow® Acoustic Monitoring and In Vivo Adjustment™
11. Darah Medical Awarded GSA Schedule, Launches Online Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical ... significant unmet medical needs in rare diseases, today announced ... webcast on Monday, April 3 during ENDO 2017, the ... Orlando, Florida , to discuss new data regarding ... TransCon PTH and TransCon CNP). Ascendis is ...
(Date:3/23/2017)... , March 23, 2017  A new ... and accurate identification of individuals who carry ... for a rare yet potentially deadly side effect ... bipolar disorder.  The gene HLA-B*15:02 is ... such as Stevens-Johnson syndrome and toxic epidermal necrolysis ...
(Date:3/23/2017)... , March 23, 2017 ... from the TACTI-mel trial of IMP321 in combination with ... the first (1mg/kg) cohort experiencing a complete response. Recruitment ... cohort is expected to be fully recruited by Q317. ... the AIPAC breast cancer study are expected mid-year (recruitment ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... PAINWeekEnd ... at 10 North Broadway Avenue, will be an educational and exciting program providing ... in the management of chronic pain. , Oklahoma is in a healthcare crisis. ...
(Date:3/23/2017)... Austin, TX (PRWEB) , ... March 23, 2017 , ... ... fist-sized organs that pack a punch when it comes to maintaining good health. Every ... every 30 minutes, your kidneys filter every drop of your blood, eliminating waste, regulating ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The TouchPoint Solution, ... the world to manage stress and anxiety. , “Buzzies change the way we ... and co-founder of Buzzies. , Since its launch date in December 2016, The TouchPoint ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ?This conference will prominently feature 150+ Hospital and ... and Director, AMN Healthcare: Susan Salka , 43rd President of the United States ... Big Fight My Life In and Out of the Ring: Sugar Ray Leonard , ...
(Date:3/23/2017)... ... March 23, 2017 , ... It’s that time of year again! Time to ... summer internships , which can be frustrating when they don’t even know how ... Group, a boutique public relations firm outside of Philadelphia, have offered these three tips ...
Breaking Medicine News(10 mins):